Editorial commentary: A narrative on understanding continuity in advancing research and development to optimise the safety of next-generation platelet bioproducts and patient-centred outcomes

Transfusion and Apheresis Science · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles